Safety and Efficacy Study of Fibrin Sealant Grifols as an Adjunct to Hemostasis During Peripheral Vascular Surgery
Public ClinicalTrials.gov record NCT01662856. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Prospective, Single-blind, Randomized, Phase III Study to Evaluate the Safety and Efficacy of Fibrin Sealant Grifols (FS Grifols) as an Adjunct to Hemostasis During Peripheral Vascular Surgery
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to demonstrate that the application of Fibrin Sealant Grifols provides a measurable benefit when compared to hemostasis achieved through conventional surgical technique (suture) and by standard hemostatic action, such as mechanical pressure through manual compression. This study has a Preliminary Part (I) in which all subjects are treated with Fibrin Sealant Grifols and a Primary Part (II) in which subjects are randomized in a 2:1 ratio to either Fibrin Sealant Grifols or manual compression.
Study identification
- NCT ID
- NCT01662856
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 225 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- Not listed
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 2012 (Type not available)
- Primary completion
- Dec 2015 (Actual)
- Completion
- Dec 2015 (Actual)
- Last update posted
- Apr 6, 2017
2012 – 2015
United States locations
- U.S. sites
- 27
- U.S. states
- 16
- U.S. cities
- 26
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| 407 | Florence | Alabama | 35630 | — |
| 125 | Palo Alto | California | 94304 | — |
| 119 | San Diego | California | 92120 | — |
| 149 | Jacksonville | Florida | 32207 | — |
| 148 | Jacksonville | Florida | 32216 | — |
| 137 | Tampa | Florida | 33606 | — |
| 140 | Atlanta | Georgia | 30303 | — |
| 114 | Iowa City | Iowa | 52242 | — |
| 110 | Lexington | Kentucky | 40536 | — |
| 146 | Baton Rouge | Louisiana | 70809 | — |
| 132 | New Orleans | Louisiana | 70112 | — |
| 129 | Baltimore | Maryland | 21201 | — |
| 135 | Bethesda | Maryland | 20889 | — |
| 102 | Boston | Massachusetts | 02118 | — |
| 406 | Manhasset | New York | 11030 | — |
| 113 | Stony Brook | New York | 11794 | — |
| 142 | The Bronx | New York | 10467-2401 | — |
| 409 | Dayton | Ohio | 45409 | — |
| 104 | Toledo | Ohio | 43606 | — |
| 100, 128 | Pittsburgh | Pennsylvania | 15212 | — |
| 115 | West Reading | Pennsylvania | 19611 | — |
| 147 | Fort Worth | Texas | 76107 | — |
| 402 | Houston | Texas | 77024 | — |
| 139 | Salt Lake City | Utah | 84132-3201 | — |
| 103 | Seattle | Washington | 98104 | — |
| 138 | Tacoma | Washington | 98431 | — |
| 111 | Madison | Wisconsin | 53792 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 11 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01662856, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 6, 2017 · Synced Oct 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01662856 live on ClinicalTrials.gov.